BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
Pomalidomide-PEG4-Ph-NH2 is an effective PROTAC inhibitor, that has the ability to prevent the pathway of E3 ligase ligand-linker conjugation. The molecular weight of the compound is 540.57, and its molecular formula is C27H32N4O8.
Molecular Weight
540.57
Molecular Formula
C27H32N4O8
Form
Lyophilized powder
Purity
≥98%
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Identity
Confirmed by NMR/HPLC/MS.
Applications
Pomalidomide-PEG4-Ph-NH2 can be used for its effects on immune modulation and anti-inflammatory properties in various hematological malignancies.
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.